A higher IGF2BP1 expression level was positively correlated with the depth of tumor invasion (T1 − 2 versus T3 − 4), but no significant differences were found in other clinicopathological features, such as sex, age, histologic grade, lymph node metastasis and clinical stage (Table 1). The gene discussed is IGF2BP1; the disease is neoplasm.